Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Roberto Pili, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Hematology Oncology Medical Group Inc
Alhambra, California, United States
- Comprehensive Blood and Cancer Center
Bakersfield, California, United States
- Providence Saint Joseph'S Medical Center (psjmc)
Burbank, California, United States
- Pacific Oncology & Hematology Associates
Encinitas, California, United States
- Virginia K. Crosson Cancer Center
Fullerton, California, United States
- Pacific Shores Medical Group
Long Beach, California, United States
- Ucla Clinical Research Unit
Los Angeles, California, United States
- North Valley Hematology/oncology Medical Group, the Thomas and Dorothy Leavey Cancer Center
Northridge, California, United States
- Ventura County Hematology-Oncology Specialists
Oxnard, California, United States
- Cancer Care Associates Medical Group, Inc
Redondo Beach, California, United States
- Sansum Santa Barbara Medical Foundation Clinic
Santa Barbara, California, United States
- Santa Barbara Hematology Oncology Medical Group, Inc.
Santa Barbara, California, United States
- Central Coast Medical Oncology Corporation
Santa Maria, California, United States
- Stanford University Medical Center-Cancer Center
Stanford, California, United States
- University of Miami School of Medicine
Miami, Florida, United States
- Peachtree Hematology and Oncology
Atlanta, Georgia, United States
- Oncology Hematology Associates of Central Illinois,pc
Peoria, Illinois, United States
- Ochsner Cancer Institute
New Orleans, Louisiana, United States
- the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Park Nicollet Institute
Saint Louis Park, Minnesota, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Columbia University Medical Center
New York, New York, United States
- Staten Island Urological Research
Staten Island, New York, United States
- Biomedical Research Alliance of New York (brany)
The Bronx, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
- Marshfield Clinic Foundation
Marshfield, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2005
- Primary completion
- 30 Jun 2007
- Completion
- 31 Aug 2008
- Last update posted
- 30 Jan 2009
- Registered enrollment
- 70
- Registry id
- NCT00111618
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.